Target intelligence / Profile preview

Polyhistidine triad protein D (PhtD) (PhtD)

Target
PhtD
Molecular classification
Bacterial surface protein, Zinc-binding protein, Antigen
01

Overview

Polyhistidine triad protein D (PhtD) is a highly conserved surface protein of Streptococcus pneumoniae that plays a vital role in the pathogen's survival and virulence. It belongs to the Pht family, characterized by multiple histidine triad (HxxHxH) motifs that bind divalent metal ions, specifically zinc, which is essential for bacterial metabolism and resistance to host-induced metal stress (Rioux et al., 2002, PubMed: 12165599). Beyond metal homeostasis, PhtD facilitates bacterial adherence to the respiratory epithelium and aids in immune evasion by binding to host complement factor H, thereby inhibiting the alternative complement pathway (Ogunniyi et al., 2009, PubMed: 19528208). Due to its presence across almost all pneumococcal serotypes, PhtD is a primary candidate for serotype-independent protein vaccines (Pancotto et al., 2013, PubMed: 23414371). Clinical trials have shown that PhtD-based vaccines are well-tolerated and capable of inducing robust antibody responses that enhance the opsonophagocytic killing of the bacteria (Hambidge et al., 2011, PubMed: 21502370). Research indicates that targeting PhtD can potentially reduce both invasive pneumococcal disease and mucosal colonization, addressing limitations of current polysaccharide-conjugate vaccines.

Other names
PhtDBVH-11Pneumococcal histidine triad protein DSP0361
02

Mechanism of action

Induction of protective humoral immunity, specifically opsonophagocytic antibodies that facilitate clearance of Streptococcus pneumoniae and prevent mucosal colonization.

03

Biological functions

Zinc ion homeostasisBacterial adhesionComplement evasionMetal ion transport
04

Disease associations

InfectionPneumoniaMeningitisOtitis mediaBacteremia
05

Safety considerations

Immunogenicity variability across populationsPotential for serotype-independent but strain-specific variation in expression
06

Interacting drugs

GSK2189242A

1 more in the full profile.

07

Biomarkers

Anti-PhtD IgG antibody concentrationOpsonophagocytic activity (OPA) titers

Beyond the preview

Go deeper on Polyhistidine triad protein D (PhtD) (PhtD).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Polyhistidine triad protein D (PhtD) (PhtD).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call